Total 608 patients with PsA | T0 | T6 | T12 | T24 | P value |
TJ (0–68), mean (SD) | 8.02 (6.82) | 3.64 (5.07) | 2.85 (4.81) | 1.60 (3.05) | <0.01 |
SJ (0–66), mean (SD) | 2.25 (2.82) | 0.82 (1.53) | 0.61 (1.87) | 0.26 (0.69) | 0.03 |
LEI (0–6), mean (SD) | 1.62 (1.83) | 0.88 (1.45) | 0.39 (0.95) | 0.19 (0.62) | 0.04 |
Dactylitis (0–20) number digit, mean (SD) | 0.28 (1.27) | 0.07 (0.46) | 0.03 (0.27) | 0.01 (0.11) | 0.05 |
PASI (0–72), mean (SD) | 4.24 (7.38) | 1.69 (3.91) | 0.81 (2.21) | 0.88 (3.21) | <0.01 |
ESR (0–25) (mm/hour), mean (SD) | 21.13 (17.08) | 15.71 (13.11) | 14.88 (13.59) | 14.94 (12.45) | 0.03 |
CRP (0–6) (mg/L), mean (SD) | 6.45 (9.82) | 4.13 (6.27) | 3.45 (5.01) | 3.49 (5.41) | 0.03 |
DAPSA (0–164), mean (SD) | 25.29 (11.14) | 14.07 (9.69) | 12.12 (9.97) | 7.69 (4.51) | <0.01 |
ASDAS (0–6), mean (SD) | 3.26 (0.88) | 2.11 (1.03) | 1.82 (1.02) | 1.60 (0.69) | 0.02 |
HAQ-S (0–8), mean (SD) | 1.28 (8.23) | 0.89 (0.69) | 0.69 (0.71) | 0.53 (0.64) | 0.05 |
VAS-pain (0–10), mean (SD) | 6.70 (1.67) | 4.30 (2.28) | 3.28 (2.51) | 2.52 (2.32) | 0.02 |
VAS-gh (0–10), mean (SD) | 6.71 (4.93) | 4.25 (2.24) | 3.10 (2.44) | 2.41 (2.31) | 0.02 |
BASDAI (0–10), mean (SD) | 5.22 (2.17) | 3.52 (2.53) | 3.35 (2.16) | 2.60 (1.61) | 0.03 |
BASFI (0–10), mean (SD) | 5.17 (2.14) | 3.72 (2.02) | 2.82 (1.87) | 2.48 (1.34) | 0.03 |
Data are expressed as mean (SD). Values were computed by means of a χ2 test (for proportion) or Wilcoxon’s test (for continuous data), p≤0.05 T24 vs T0.
ASDAS, Ankylosing Spondylitis Disease Activity Score; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C reactive protein; DAPSA, Disease Activity Index for Psoriatic Arthritis; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire modified for spondyloarthritis; LEI, Leeds Enthesitis Index; PASI, Psoriasis Area Severity Index; SJ, swollen joint; TJ, tender joint; VAS-gh, Visual Analogue Scale global health; VAS-pain, Visual Analogue Scale pain.